Interplay between ER stress and autophagy: A possible mechanism in multiple sclerosis pathology.


Journal

Experimental and molecular pathology
ISSN: 1096-0945
Titre abrégé: Exp Mol Pathol
Pays: Netherlands
ID NLM: 0370711

Informations de publication

Date de publication:
06 2019
Historique:
received: 31 03 2019
revised: 18 04 2019
accepted: 27 04 2019
pubmed: 3 5 2019
medline: 26 2 2020
entrez: 4 5 2019
Statut: ppublish

Résumé

Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease of the central nervous system that results in demyelination, neurodegeneration, and axonal loss. During MS pathology, autoreactive T cells specific for self-antigens migrate the blood-brain-barrier and are responsible for the axonal and neuronal damage. ER stress, a disruption in cellular homeostasis due to the accumulation of misfolded proteins, is a hallmark of MS pathology. In response to the homeostatic imbalance, ER stress activates the unfolded protein response, an intricate system of signaling pathways that aims to restore cellular balance. During the UPR, various autophagy pathways are also activated. Autophagy is a diverse network of regulatory catabolic processes which direct the clearance of damaged and unnecessary organelles and proteins while recycling necessary cellular components. In respect to its role in the health of the immune system, autophagy is critical to the survival and proliferation of T cells. This review consolidates current knowledge and recent literature about ER stress, UPR, and autophagy in MS and implicate their crosstalk as a characteristic feature of MS, potentially aiding in the development of novel therapeutic strategies for MS research.

Identifiants

pubmed: 31047874
pii: S0014-4800(19)30233-3
doi: 10.1016/j.yexmp.2019.04.016
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

183-190

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Sanketh Andhavarapu (S)

Department of Neurology, University of Maryland, Baltimore, MD 21201, United States of America.

Fahad Mubariz (F)

Department of Neurology, University of Maryland, Baltimore, MD 21201, United States of America.

Muhammad Arvas (M)

Department of Neurology, University of Maryland, Baltimore, MD 21201, United States of America.

Christopher Bever (C)

Department of Neurology, University of Maryland, Baltimore, MD 21201, United States of America; VA Medical Center, Baltimore, MD 21201, United States of America; VA Multiple Sclerosis Center of Excellence East, Baltimore, MD 21201, United States of America.

Tapas K Makar (TK)

Department of Neurology, University of Maryland, Baltimore, MD 21201, United States of America; VA Medical Center, Baltimore, MD 21201, United States of America; VA Multiple Sclerosis Center of Excellence East, Baltimore, MD 21201, United States of America. Electronic address: tmakar@som.umaryland.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH